Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
26 01 2021
Historique:
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 10 6 2021
Statut: ppublish

Résumé

Therapies for heart failure with preserved ejection fraction (HFpEF) are lacking. Growth hormone-releasing hormone agonists (GHRH-As) have salutary effects in ischemic and nonischemic heart failure animal models. Accordingly, we hypothesized that GHRH-A treatment ameliorates chronic kidney disease (CKD)-induced HFpEF in a large-animal model. Female Yorkshire pigs (

Identifiants

pubmed: 33468654
pii: 2019835118
doi: 10.1073/pnas.2019835118
pmc: PMC7848727
pii:
doi:

Substances chimiques

Cardiotonic Agents 0
Connectin 0
N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38 0
Peptide Fragments 0
Protein Isoforms 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0
Sermorelin 86168-78-7
Growth Hormone-Releasing Hormone 9034-39-3
Creatinine AYI8EX34EU
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL107110
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL113460
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA136387
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134558
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600012C
Pays : United States

Déclaration de conflit d'intérêts

Competing interest statement: A.V.S and J.M.H. are listed as co-inventors on patents on GHRH analogs, which were assigned to the University of Miami and Veterans Affairs Department. J.M.H. previously owned equity in Biscayne Pharmaceuticals, licensee of intellectual property used in this study. Biscayne Pharmaceuticals did not provide funding for this study. J.M.H. is the chief scientific officer, a compensated consultant, and advisory board member for Longeveron and holds equity in Longeveron. J.M.H. is also the co-inventor of intellectual property licensed to Longeveron. Longeveron did not play a role in the design, conduct, or funding of the study. J.M.H.’s relationships are reported to the University of Miami, and an appropriate management plan is in place. I.H.S. contributed to this manuscript in her personal capacity. The opinions expressed in this article are the author's own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.

Références

N Engl J Med. 2014 Apr 10;370(15):1383-92
pubmed: 24716680
N Engl J Med. 2004 Nov 11;351(20):2112-4
pubmed: 15533853
J Clin Invest. 2000 Sep;106(5):697-703
pubmed: 10974023
Circ Res. 2012 Jan 6;110(1):174-89
pubmed: 22223213
Circ Res. 2002 Oct 4;91(7):594-600
pubmed: 12364387
Circulation. 2013 Jan 15;127(2):213-23
pubmed: 23224061
Peptides. 2014 Feb;52:104-12
pubmed: 24373935
Circ Res. 2019 May 24;124(11):1598-1617
pubmed: 31120821
Circ Res. 2004 Mar 5;94(4):505-13
pubmed: 14707027
J Am Heart Assoc. 2015 Mar 31;4(4):
pubmed: 25827134
J Am Coll Cardiol. 1992 Nov 15;20(6):1318-25
pubmed: 1430681
Circulation. 2020 Mar 24;141(12):1001-1026
pubmed: 32202936
J Surg Res. 2006 Oct;135(2):370-9
pubmed: 16815448
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14589-94
pubmed: 25246556
ESC Heart Fail. 2020 Oct 19;:
pubmed: 33073523
Eur Heart J. 2018 Aug 7;39(30):2780-2792
pubmed: 29905796
Circ Res. 2015 Mar 27;116(7):1254-68
pubmed: 25814686
Int J Mol Sci. 2020 Jan 30;21(3):
pubmed: 32019245
J Clin Invest. 2005 Mar;115(3):509-17
pubmed: 15765132
Nat Protoc. 2012 Jul 12;7(8):1479-96
pubmed: 22790084
Circulation. 2015 Jan 20;131(3):269-79
pubmed: 25398313
Int J Mol Sci. 2018 Jan 18;19(1):
pubmed: 29346331
Circulation. 2000 Dec 19;102(25):3074-9
pubmed: 11120697
J Biol Chem. 2013 Mar 1;288(9):6522-33
pubmed: 23319593
Circ Res. 2006 May 12;98(9):1177-85
pubmed: 16574901
Cardiovasc Res. 2021 Mar 21;117(4):999-1014
pubmed: 32717061
Eur Heart J. 2006 Oct;27(19):2338-45
pubmed: 16963472
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2604-9
pubmed: 20133784
Endocrinology. 2019 Jul 1;160(7):1600-1612
pubmed: 31070727
J Vis Exp. 2014 Apr 21;(86):
pubmed: 24798397
Nat Rev Immunol. 2015 Feb;15(2):117-29
pubmed: 25614321
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12033-12038
pubmed: 29078377
Circulation. 2012 Aug 14;126(7):830-9
pubmed: 22806632
J Gen Physiol. 2019 Jan 7;151(1):42-52
pubmed: 30567709
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):559-63
pubmed: 22203988
Oncotarget. 2015;6(12):9728-39
pubmed: 25797248
J Vasc Interv Radiol. 2003 Jan;14(1):89-98
pubmed: 12525592
Circ Res. 2009 Mar 27;104(6):780-6
pubmed: 19179657
J Am Coll Cardiol. 2017 Nov 14;70(20):2504-2515
pubmed: 29145950
N Engl J Med. 2008 Dec 4;359(23):2456-67
pubmed: 19001508
Lancet. 2003 Sep 6;362(9386):777-81
pubmed: 13678871
Nature. 2019 Apr;568(7752):351-356
pubmed: 30971818
Eur Heart J. 2019 Oct 21;40(40):3297-3317
pubmed: 31504452
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17260-5
pubmed: 25404316
Cardiovasc Res. 2021 Jan 21;117(2):495-507
pubmed: 32396609
Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H771-8
pubmed: 26188021
Circ Res. 2001 Aug 3;89(3):198-200
pubmed: 11485969
J Biol Chem. 2010 Sep 10;285(37):28938-45
pubmed: 20643651
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1407-18
pubmed: 26342070

Auteurs

Angela C Rieger (AC)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Luiza L Bagno (LL)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Alessandro Salerno (A)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Victoria Florea (V)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Jose Rodriguez (J)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Marcos Rosado (M)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Darren Turner (D)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Raul A Dulce (RA)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Lauro M Takeuchi (LM)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Rosemeire M Kanashiro-Takeuchi (RM)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.
Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136.

Peter Buchwald (P)

Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136.
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Amarylis C B A Wanschel (ACBA)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.

Wayne Balkan (W)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136.

Ivonne H Schulman (IH)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136.
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136.
Katz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL 33136.

Andrew V Schally (AV)

Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136; andrew.schally@va.gov jhare@med.miami.edu.
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136.
Endocrine, Polypeptide and Cancer Institute, Veteran Affairs Medical Center, Miami, FL 33125.

Joshua M Hare (JM)

Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; andrew.schally@va.gov jhare@med.miami.edu.
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH